
Rhapsody Venture Partners
Description
Rhapsody Venture Partners is a specialized venture capital firm based in Cambridge, Massachusetts, dedicated to investing in and actively operating industrial science and deep technology startups. The firm focuses on early-stage companies, typically from Seed to Series A, that are developing groundbreaking innovations in sectors such as advanced materials, industrial IoT, manufacturing, energy, chemicals, and life sciences tools. Their investment thesis centers on hard science and deep tech solutions that address significant industrial challenges and opportunities.
What distinguishes Rhapsody is its highly operational approach. Beyond providing capital, the firm's partners and team members actively engage with portfolio companies, offering hands-on support in areas like product development, market strategy, and scaling operations. They often take a lead or co-lead position in funding rounds, demonstrating a strong commitment to the companies they back. This deep involvement aims to accelerate the commercialization of complex scientific and engineering breakthroughs.
Rhapsody Venture Partners typically provides initial investments ranging from $1 million to $5 million, targeting companies that possess proprietary technology and a clear path to industrial application. The firm recently closed its third fund, Rhapsody Venture Partners III, at $100 million in March 2021, underscoring its continued commitment and capacity to support a growing portfolio of industrial innovation. With a track record of numerous investments, including participation in 49 funding rounds according to Crunchbase, Rhapsody has established itself as a key player in the industrial deep tech ecosystem.
Investor Profile
Rhapsody Venture Partners has backed more than 39 startups, with 2 new investments in the last 12 months alone. The firm has led 20 rounds, about 51% of its total and boasts 0 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Seed, Series A, Series Unknown rounds (top funding stages).
- Majority of deals are located in United States, Canada, United Kingdom.
- Strong thematic focus on Biotechnology, Food and Beverage, Autonomous Vehicles.
- Led 1 rounds in the past year.
- Typical check size: $1M – $5M.
Stage Focus
- Seed (49%)
- Series A (31%)
- Series Unknown (8%)
- Series B (5%)
- Series C (3%)
- Convertible Note (3%)
- Pre Seed (3%)
Country Focus
- United States (77%)
- Canada (13%)
- United Kingdom (8%)
- Finland (3%)
Industry Focus
- Biotechnology
- Food And Beverage
- Autonomous Vehicles
- Agriculture
- Agtech
- Industrial Engineering
- Manufacturing
- Mechanical Engineering
- Indoor Positioning
- Mapping Services
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.